Open AccessAssociation of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen
Author(s) -
Chonlaphat Sukasem,
Monpat Chamnanphon,
Khunthong Pechatanan,
Santon,
Puangpetch,
Wasun Chantratita,
Ekawat Pasomsub,
Wilai Noonpakdee,
Insee Sensorn
Publication year - 2013
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s42330
Subject(s) - cyp2c19 , medicine , cyp2d6 , breast cancer , genotype , tamoxifen , oncology , pharmacogenetics , gastroenterology , allele , cancer , genetics , biology , gene , cytochrome p450 , metabolism
To investigate the impact of CYP2D6 and CYP2C19 polymorphisms in predicting tamoxifen efficacy and clinical outcomes in Thai breast cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom